Determinants of Fibrin d -Dimer in the Edinburgh Artery Study
- 1 August 1995
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 15 (8) , 1094-1097
- https://doi.org/10.1161/01.atv.15.8.1094
Abstract
Abstract There is growing evidence that fibrin d -dimer is associated with coronary and peripheral atherosclerosis. Using data from the Edinburgh Artery Study, we examined the distribution of fibrin d -dimer in 1592 men and women 55 to 74 years old and assessed its relationship with a range of cardiovascular risk factors. Fibrin d -dimer levels were higher in women than in men ( P ≤.05) and increased with age ( P ≤.001). Current cigarette smokers had higher levels than ex-smokers, who, in turn, had higher levels than those who had never smoked. On multiple regression analyses with age and plasma fibrinogen as covariates, only lifetime smoking in men and systolic blood pressure in women were independent predictors of fibrin d -dimer levels. Since fibrin d -dimer does not appear to be independently related to many of the common cardiovascular risk factors, it may be a useful index of the thrombotic contribution to arterial disease.Keywords
This publication has 14 references indexed in Scilit:
- Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment.Heart, 1995
- Smoking, haemostatic factors and lipid peroxides in a population case control study of peripheral arterial diseaseAtherosclerosis, 1993
- Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart diseaseThe Lancet, 1993
- Antithrombin III and arterial diseaseThe Lancet, 1991
- Edinburgh Artery Study: Prevalence of Asymptomatic and Symptomatic Peripheral Arterial Disease in the General PopulationInternational Journal of Epidemiology, 1991
- Fibrin and Fibrinogen-Related Antigens in Patients with Stable and Unstable Coronary Artery DiseaseNew England Journal of Medicine, 1987
- PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTIONThe Lancet, 1987
- HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDYThe Lancet, 1986
- The effects of hepatocyte stimulating factor on fibrinogen biosynthesis in hepatocyte monolayers.The Journal of cell biology, 1985
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionNew England Journal of Medicine, 1984